10q10k10q10k.net
Tilray Brands, Inc.

Tilray Brands, Inc.TLRYEarnings & Financial Report

Nasdaq

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

TLRY Q2 2026 Key Financial Metrics

Revenue

$217.5M

Gross Profit

$57.5M

Operating Profit

$-22.3M

Net Profit

$-44.9M

Gross Margin

26.4%

Operating Margin

-10.2%

Net Margin

-20.7%

YoY Growth

3.1%

EPS

$-0.41

Financial Flow

Tilray Brands, Inc. Q2 2026 Financial Summary

Tilray Brands, Inc. reported revenue of $217.5M for Q2 2026, with a net profit of $-44.9M (-20.7% margin). Cost of goods sold was $160.0M, operating expenses totaled $79.8M.

Key Financial Metrics

Total Revenue$217.5M
Net Profit$-44.9M
Gross Margin26.4%
Operating Margin-10.2%
Report PeriodQ2 2026

Tilray Brands, Inc. Annual Revenue by Year

Tilray Brands, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $821.3M).

YearAnnual Revenue
2025$821.3M
2024$788.9M
2023$627.1M
2022$628.4M

Income Statement

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$188.3M$229.9M$200.0M$210.9M$185.8M$224.5M$209.5M$217.5M
YoY Growth29.4%24.8%13.1%8.9%-1.4%-2.3%4.7%3.1%

Balance Sheet

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Assets$4.21B$4.22B$4.26B$4.19BN/A$2.07B$2.08B$2.10B
Liabilities$869.8M$778.5M$778.5M$738.1MN/A$584.8M$562.0M$552.1M
Equity$3.36B$3.44B$3.48B$3.47B$2.70B$1.51B$1.54B$1.58B

Cash Flow

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Operating CF$-15.4M$30.7M$-35.3M$-40.7M$-5.8M$-12.8M$-1.3M$-8.5M